Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Late-breaking clinical data presented at EuroPCR 2023 in Paris demonstrated Elixir Medical’s DynamX Bioadaptor restores vessel motion and function with better effectiveness at 12 months compared to a leading drug-eluting stent (DES).

News | EuroPCR

EuroPCR Late-Breaking Clinical Trial Data Finds Effectiveness of Elixir Medical’s DynamX Bioadaptor for PCI Treatment

May 17, 2023 — Elixir Medical has reported that important data were presented at a late-breaking clinical session during ...

May 17, 2023

Heart Rhythm 2023, the society's 44th annual meeting, taking place May 19-21, in New Orleans

Feature | HRS | By Melinda Taschetta-Millane

HRS23 Announces Late-breaking Clinical Trials and Science Sessions

The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical ...

May 17, 2023

Along with this latest IDE approval for the treatment of Small Vessel indication, Concept Medical received two other IDE approvals for the Magic Touch SCB family of products for the treatment of coronary In-Stent Restenosis (ISR) indication and Below-the-Knee indication (PTA)

News | Drug-Eluting Balloons

Concept Medical's Receives FDA Approval for the MagicTouch-Sirolimus Coated Balloon

May 12, 2023 — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel ...

May 12, 2023

News | Stroke

Under 40s with Mental Health Problems Have Elevated Risks of Heart Attack and Stroke

May 11, 2023 — Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a heart ...

May 11, 2023

The randomized controlled double-blind trial evaluated the effect of hyperbaric oxygen therapy (HBOT) on the cardiac function of long COVID patients

News | Coronavirus (COVID-19)

Oxygen Therapy Improves Heart Function in Patients with Long COVID

May 10, 2023 — A small randomized trial in patients with post-COVID syndromehas found that hyperbaric oxygen therapy ...

May 10, 2023

This research-use-only offering supports the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases

News | Womens Cardiovascular Health

Women are Underrepresented in Cardiovascular Clinical Trials

May 10, 2023 — A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials ...

May 10, 2023

News | Heart Valve Technology

Edwards' Aortic Valve with Resilia Tissue Shows Favorable Durability, Safety and Efficacy Outcomes in 7-year Data

May 9, 2023 — Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structu ...

May 09, 2023

This recent advance fulfils the requirements needed to promote an efficient translation of innovations and new treatments from the bench to the bedside in this field

News | Stroke

New Reproducible and Minimally Invasive Stroke Model Through an Endovascular Approach

May 8, 2023 — Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol ...

May 08, 2023

72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.

News | Computed Tomography (CT)

Rapid Onsite FFR-CT Algorithm Helps Facilitates Clinical Adoption

May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high ...

May 05, 2023

This study evaluates SELUTION SLR in the treatment of occlusive disease of the superficial femoral artery (SFA) and proximal popliteal artery (PPA) and has been designed to support FDA approval

News | Drug-Eluting Balloons

MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA

May 4, 2023 — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the Ca ...

May 04, 2023

Investigators are one step closer to achieving this breakthrough in preventive healthcare and offering patients personalized predictions of their heart health thanks to a novel deep-learning tool and artificial intelligence (AI) algorithm developed at Cedars-Sinai.

News | Artificial Intelligence

New AI Tool Developed at Cedars-Sinai Can Predict Adverse Cardiac Events Like Heart Attacks, and Show How Risk Changes Over Time

May 4, 2023 — What if you could predict if-or when-your patient might experience a heart attack, cardiac arrest or ...

May 04, 2023

A new book written by and for interventional cardiologists provides a collection of detailed case studies, clinical data and imagery, according to Cedars-Sinai, whose team from Smidt Heart Institute is among the editors of the publication.

Feature | Cardiovascular Education | Christine Book

Book Offering Collection of Complex Interventional Cardiology Cases Published by Team from Cedars-Sinai Smidt Heart Institute

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute a ...

May 04, 2023

A team led by researchers at The University of Texas at Austin has developed an ultrathin, lightweight electronic tattoo, or e-tattoo, that attaches to the chest for continuous, mobile heart monitoring outside of a clinical setting

News | Wearables

Chest e-Tattoo Boasts Major Improvements in Heart Monitoring

May 3, 2023 — A new flexible, wearable medical device could provide a major boost in the fight against heart disease ...

May 03, 2023

Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP Platform

News | EP Device Monitoring Systems

BioSig to Highlight New Data from the PURE EP Platform at Heart Rhythm 2023

May 3, 2023 — BioSig Technologies, Inc., a medical technology company delivering unprecedented accuracy and precision to ...

May 03, 2023

MOJAVE study on track to start in Q2 2023 as planned, with initial data by year-end

News | Pharmaceuticals

Sequana Medical Announces FDA Clearance of IND Application for DSR 2.0 for Treatment of Congestive Heart Failure

May 2, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

May 02, 2023